Sex- and time-dependent role of insulin regulated aminopeptidase in lipopolysaccharide-induced inflammation.
IRAP
LPS
gram-negative sepsis
inflammation
insulin regulated aminopeptidase
lipopolysaccharide
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2024
2024
Historique:
received:
18
07
2024
accepted:
16
09
2024
medline:
21
10
2024
pubmed:
21
10
2024
entrez:
21
10
2024
Statut:
epublish
Résumé
The enzyme, insulin regulated aminopeptidase (IRAP), is expressed in multiple immune cells such as macrophages, dendritic cells and T cells, where it plays a role in regulating the innate and adaptive immune response. There is a genetic association between IRAP and survival outcomes in patients with septic shock where a variant of its gene was found to be associated with increased 28-day mortality. This study investigated the role for IRAP in a lipopolysaccharide (LPS)-induced inflammatory response which is thought to model facets of the systemic inflammation observed in the early stages of human gram-negative sepsis. The frequencies and activation of splenic immune cell populations were investigated in the IRAP knockout (KO) mice compared to the wildtype controls over a period of 4-, 24-, or 48-hours following LPS stimulation. Dendritic cells isolated from the spleen of female IRAP KO mice, displayed significant increases in the activation markers CD40, CD86 and MHCII at 24 hours after LPS induction. A modest heightened pro-inflammatory response to LPS was observed with increased expression of activation marker CD40 in M1 macrophages from male IRAP knockout mice. Observations
Identifiants
pubmed: 39430768
doi: 10.3389/fimmu.2024.1466692
pmc: PMC11486674
doi:
Substances chimiques
Lipopolysaccharides
0
Cystinyl Aminopeptidase
EC 3.4.11.3
leucyl-cystinyl aminopeptidase
EC 3.4.11.3
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1466692Informations de copyright
Copyright © 2024 Vear, Chakraborty, Fahimi, Ferens, Widdop, Samuel, Gaspari, van Endert and Chai.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.